These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18508119

  • 1. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.
    Engin E, Treit D.
    Neuropeptides; 2008 Aug; 42(4):411-21. PubMed ID: 18508119
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats.
    Nascimento Häckl LP, Carobrez AP.
    Neurobiol Learn Mem; 2007 Sep; 88(2):177-85. PubMed ID: 17540583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
    Santos CJ, Stern CA, Bertoglio LJ.
    Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
    [Abstract] [Full Text] [Related]

  • 9. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA.
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of the dorsal and ventral hippocampus in fear and memory of a shock-probe experience.
    McEown K, Treit D.
    Brain Res; 2009 Jan 28; 1251():185-94. PubMed ID: 19061870
    [Abstract] [Full Text] [Related]

  • 13. Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety.
    Beiderbeck DI, Neumann ID, Veenema AH.
    Eur J Neurosci; 2007 Dec 28; 26(12):3597-605. PubMed ID: 18052969
    [Abstract] [Full Text] [Related]

  • 14. Anxiolytic-like effects of substance P administration into the dorsal, but not ventral, hippocampus and its influence on serotonin.
    Carvalho MC, Masson S, Brandão ML, de Souza Silva MA.
    Peptides; 2008 Jul 28; 29(7):1191-200. PubMed ID: 18490080
    [Abstract] [Full Text] [Related]

  • 15. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
    Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):482-95. PubMed ID: 17188790
    [Abstract] [Full Text] [Related]

  • 16. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
    Mak P, Broussard C, Vacy K, Broadbear JH.
    J Psychopharmacol; 2012 Apr 30; 26(4):532-42. PubMed ID: 21890582
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A, Maehara S, Ise S, Hikichi H, Fukushima M, Suzuki G, Kimura T, Tanak T, Ito S, Kawamoto H, Ohta H.
    J Pharmacol Exp Ther; 2008 Aug 30; 326(2):577-86. PubMed ID: 18487514
    [Abstract] [Full Text] [Related]

  • 18. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.
    Cornélio AM, Nunes-de-Souza RL.
    Behav Brain Res; 2007 Mar 12; 178(1):82-9. PubMed ID: 17207863
    [Abstract] [Full Text] [Related]

  • 19. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours.
    Rostami P, Hajizadeh-Moghaddam A, Zarrindast MR.
    Physiol Behav; 2006 May 30; 87(5):891-6. PubMed ID: 16600315
    [Abstract] [Full Text] [Related]

  • 20. Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats.
    Shah AA, Sjovold T, Treit D.
    Eur J Neurosci; 2004 Jun 30; 19(12):3393-7. PubMed ID: 15217397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.